Alberto M Martelli Selected Research

2,2-bis(6-bromo-3-indolyl) ethylamine

4/2018

Marine bisindole alkaloid: A potential apoptotic inducer in human cancer cells.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Alberto M Martelli Research Topics

Disease

85	Neoplasms (Cancer) 04/2022 - 01/2002
21	Leukemia 01/2021 - 03/2002
18	Precursor Cell Lymphoblastic Leukemia-Lymphoma (Acute Lymphoblastic Leukemia) 02/2020 - 09/2008
17	Precursor T-Cell Lymphoblastic Leukemia-Lymphoma (T-ALL) 01/2020 - 09/2008
15	Breast Neoplasms (Breast Cancer) 01/2021 - 01/2008
12	Pancreatic Neoplasms (Pancreatic Cancer) 01/2022 - 09/2015
10	Acute Myeloid Leukemia (Acute Myelogenous Leukemia) 08/2013 - 01/2005
7	Prostatic Neoplasms (Prostate Cancer) 01/2020 - 08/2007
6	Neoplasm Metastasis (Metastasis) 01/2022 - 07/2014
5	Hematologic Neoplasms (Hematological Malignancy) 01/2022 - 06/2006
4	Carcinogenesis 01/2018 - 08/2006
4	Myelodysplastic Syndromes (Myelodysplastic Syndrome) 10/2011 - 05/2007
3	Adenocarcinoma 01/2022 - 01/2019
3	Disease Progression 01/2020 - 01/2016
3	Inflammation (Inflammations) 03/2018 - 10/2012
3	Acute Erythroblastic Leukemia (Erythroleukemia) 03/2007 - 01/2002
2	Multiple Myeloma 01/2022 - 02/2020
2	Infections 01/2020 - 12/2017
2	Hypoxia (Hypoxemia) 03/2016 - 07/2015
2	Seizures (Absence Seizure) 07/2013 - 08/2012
2	Colorectal Neoplasms (Colorectal Cancer) 12/2012 - 10/2012
1	Ewing Sarcoma (Sarcoma, Ewing) 04/2022
1	B-Cell Chronic Lymphocytic Leukemia (Chronic Lymphocytic Leukemia) 01/2022
1	BCR-ABL Positive Chronic Myelogenous Leukemia (Chronic Myelogenous Leukemia) 01/2022
1	Lymphoma (Lymphomas) 01/2022
1	Osteosarcoma (Osteogenic Sarcoma) 01/2020
1	COVID-19 01/2020

Drug/Important Bio-Agent (IBA)

23	Pharmaceutical PreparationsIBA 01/2020 - 01/2003
14	MTOR InhibitorsIBA 01/2020 - 04/2009
13	Mitogen-Activated Protein Kinase Kinases (MEKs)IBA 01/2022 - 08/2007
12	Proteins (Proteins, Gene)FDA Link 01/2021 - 01/2002
12	Phosphatidylinositol 3-Kinase (1 Phosphatidylinositol 3 Kinase)IBA 01/2020 - 01/2003
11	Phosphotransferases (Kinase)IBA 01/2021 - 09/2008
10	TOR Serine-Threonine KinasesIBA 01/2020 - 05/2007
8	Glycogen Synthase Kinase 3IBA 01/2022 - 10/2009
7	BerberineIBA 01/2022 - 12/2012
7	Mechanistic Target of Rapamycin Complex 1IBA 01/2022 - 01/2012
7	Doxorubicin (Adriamycin)FDA LinkGeneric 12/2020 - 07/2011
7	Phosphatidylinositols (Phosphatidylinositol)IBA 01/2020 - 01/2002
6	Sirolimus (Rapamycin)FDA Link 10/2018 - 10/2010
5	MicroRNAs (MicroRNA)IBA 03/2018 - 09/2015
4	Biological ProductsIBA 01/2020 - 01/2002
4	Hormones (Hormone)IBA 01/2020 - 06/2008
4	Metformin (Glucophage)FDA LinkGeneric 01/2019 - 07/2012
4	Phospholipase C betaIBA 01/2007 - 05/2002
3	Protein Isoforms (Isoforms)IBA 01/2022 - 04/2017
3	CateninsIBA 02/2020 - 12/2016
3	Fluorouracil (Carac)FDA LinkGeneric 01/2018 - 03/2008
3	Tamoxifen FDA LinkGeneric 01/2018 - 03/2008
3	CytokinesIBA 03/2016 - 12/2005
3	NF-kappa B (NF-kB)IBA 01/2016 - 02/2005
3	ErbB Receptors (EGF Receptor)IBA 01/2016 - 09/2015
3	perifosineIBA 03/2015 - 06/2006
3	LipidsIBA 09/2009 - 03/2002
3	Member 1 Subfamily B ATP Binding Cassette TransporterIBA 05/2009 - 06/2006
3	Caspase 3 (Caspase-3)IBA 05/2009 - 11/2005
3	Phosphoric Monoester Hydrolases (Phosphatases)IBA 12/2008 - 09/2008
3	LigandsIBA 11/2008 - 11/2005
2	Lamin Type A (Lamin A)IBA 04/2022 - 01/2020
2	nutlin 3IBA 01/2022 - 01/2019
2	CarcinogensIBA 01/2022 - 01/2014
2	Tumor Suppressor Protein p53IBA 01/2022 - 01/2022
2	Transcription Factors (Transcription Factor)IBA 01/2021 - 07/2015
2	epidermal growth factor receptor VIIIIBA 12/2020 - 01/2016
2	Estrogen ReceptorsIBA 01/2020 - 11/2016
2	Gemcitabine FDA Link 01/2018 - 01/2018
2	Androgen Receptors (Androgen Receptor)IBA 01/2018 - 01/2016
2	CurcuminIBA 01/2018 - 12/2017
2	ResveratrolIBA 01/2018 - 12/2017
2	Cisplatin (Platino)FDA LinkGeneric 01/2018 - 01/2018
2	Mechanistic Target of Rapamycin Complex 2IBA 01/2018 - 08/2012
2	beta CateninIBA 02/2017 - 05/2014
2	Aromatase InhibitorsIBA 11/2016 - 03/2008
2	SphingosineIBA 01/2016 - 09/2014
2	Therapeutic UsesIBA 01/2014 - 06/2010
2	Kainic Acid (Kainate)IBA 07/2013 - 08/2012
2	NucleosidesIBA 06/2013 - 05/2009
2	ChromatinIBA 12/2012 - 10/2005
2	Etoposide (VP 16)FDA LinkGeneric 07/2011 - 06/2006
2	Cyclophosphamide (Cytoxan)FDA LinkGeneric 10/2010 - 03/2008
2	CaspasesIBA 05/2009 - 04/2004
2	Tumor Necrosis Factor-alpha (Tumor Necrosis Factor)IBA 11/2008 - 12/2005
2	TensinsIBA 09/2008 - 09/2008
2	Growth Factor ReceptorsIBA 06/2008 - 03/2008
2	Antineoplastic Agents (Antineoplastics)IBA 03/2008 - 06/2006
2	IsoenzymesIBA 10/2002 - 01/2002
1	eprenetapoptIBA 01/2022
1	Daunorubicin (Cerubidine)FDA LinkGeneric 12/2020
1	Proteasome InhibitorsIBA 02/2020
1	VitaminsIBA 01/2020
1	VaccinesIBA 01/2020
1	AndrogensIBA 01/2020
1	Estradiol (Delestrogen)FDA LinkGeneric 01/2020
1	prelamin AIBA 01/2020

Therapy/Procedure

56	Therapeutics 01/2022 - 03/2002
10	Drug Therapy (Chemotherapy) 01/2020 - 06/2006
4	Radiotherapy 01/2019 - 04/2004
2	Castration 01/2020 - 01/2019
2	Combination Drug Therapy (Combination Chemotherapy) 08/2012 - 03/2011
1	TP protocol 12/2020